Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 3.29
IRTC's Cash-to-Debt is ranked higher than
58% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. IRTC: 3.29 )
Ranked among companies with meaningful Cash-to-Debt only.
IRTC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.83  Med: 1.38 Max: 3.29
Current: 3.29
0.83
3.29
Equity-to-Asset 0.67
IRTC's Equity-to-Asset is ranked higher than
64% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. IRTC: 0.67 )
Ranked among companies with meaningful Equity-to-Asset only.
IRTC' s Equity-to-Asset Range Over the Past 10 Years
Min: -4.35  Med: -2.68 Max: 0.67
Current: 0.67
-4.35
0.67
Altman Z-Score: 10.63
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 1/10

vs
industry
vs
history
Operating Margin % -24.32
IRTC's Operating Margin % is ranked lower than
76% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.86 vs. IRTC: -24.32 )
Ranked among companies with meaningful Operating Margin % only.
IRTC' s Operating Margin % Range Over the Past 10 Years
Min: -67.89  Med: -59.85 Max: -24.32
Current: -24.32
-67.89
-24.32
Net Margin % -32.62
IRTC's Net Margin % is ranked lower than
78% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.79 vs. IRTC: -32.62 )
Ranked among companies with meaningful Net Margin % only.
IRTC' s Net Margin % Range Over the Past 10 Years
Min: -72.79  Med: -63.09 Max: -32.62
Current: -32.62
-72.79
-32.62
ROA % -44.98
IRTC's ROA % is ranked lower than
86% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.23 vs. IRTC: -44.98 )
Ranked among companies with meaningful ROA % only.
IRTC' s ROA % Range Over the Past 10 Years
Min: -85.54  Med: -80.87 Max: -23.75
Current: -44.98
-85.54
-23.75
ROC (Joel Greenblatt) % -463.41
IRTC's ROC (Joel Greenblatt) % is ranked lower than
87% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.88 vs. IRTC: -463.41 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
IRTC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -898.16  Med: -536.83 Max: -463.41
Current: -463.41
-898.16
-463.41
GuruFocus has detected 2 Warning Signs with iRhythm Technologies Inc $IRTC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» IRTC's 10-Y Financials

Financials (Next Earnings Date: 2017-05-15 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

IRTC Guru Trades in

IRTC Guru Trades in

IRTC Guru Trades in

Q4 2016

IRTC Guru Trades in Q4 2016

Columbia Wanger 553,847 sh (New)
Steven Cohen 318,973 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with IRTC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:OTCPK:NNCSF, NAS:OSUR, OTCPK:KSRBF, NAS:NVCR, NAS:LMNX, NAS:ATRC, NAS:ANGO, NAS:ATRI, NAS:ELGX, AMEX:CRHM, OTCPK:HGYMF, OTCPK:AMSJF, NAS:LMAT, OTCPK:GMDTF, NAS:MLAB, NAS:ATRS, NAS:STAA, NAS:PLSE, NAS:ENTL, OTCPK:CLHLF » details
Traded in other countries:I25.Germany,
Headquarter Location:USA
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.

iRhythm Technologies Inc was incorporated in Delaware on September 14, 2006. It is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The Company has created a platform, called the ZIO Service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14, called the ZIO patch, with proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The ZIO service consists of the wearable ZIO Patch biosensor, which continuously records and stores ECG data from patient heartbeat for up to 14 days; cloud-based analysis of the recorded cardiac rhythms using Company's proprietary machine-learned algorithms; a final quality assessment review of the data by Company's certified cardiac technicians; and an easy-to-read ZIO report, a curated summary of findings that include high quality and clinically-actionable information which is sent directly to a patient's physician and can be integrated into a patient's electronic health record. The Company markets its ambulatory cardiac monitoring solution in the United States through a direct sales organization.

Ratios

vs
industry
vs
history
PB Ratio 8.04
IRTC's PB Ratio is ranked lower than
85% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.56 vs. IRTC: 8.04 )
Ranked among companies with meaningful PB Ratio only.
IRTC' s PB Ratio Range Over the Past 10 Years
Min: 6.39  Med: 8.04 Max: 9.5
Current: 8.04
6.39
9.5
PS Ratio 6.04
IRTC's PS Ratio is ranked lower than
91% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. IRTC: 6.04 )
Ranked among companies with meaningful PS Ratio only.
IRTC' s PS Ratio Range Over the Past 10 Years
Min: 4.8  Med: 6.04 Max: 7.13
Current: 6.04
4.8
7.13
EV-to-EBIT -43.00
IRTC's EV-to-EBIT is ranked lower than
99.99% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.30 vs. IRTC: -43.00 )
Ranked among companies with meaningful EV-to-EBIT only.
IRTC' s EV-to-EBIT Range Over the Past 10 Years
Min: -43  Med: -5.9 Max: -3.8
Current: -43
-43
-3.8
EV-to-EBITDA -44.63
IRTC's EV-to-EBITDA is ranked lower than
99.99% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.15 vs. IRTC: -44.63 )
Ranked among companies with meaningful EV-to-EBITDA only.
IRTC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -44.63  Med: -6.1 Max: -4
Current: -44.63
-44.63
-4
Current Ratio 8.98
IRTC's Current Ratio is ranked lower than
66% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. IRTC: 8.98 )
Ranked among companies with meaningful Current Ratio only.
IRTC' s Current Ratio Range Over the Past 10 Years
Min: 3.2  Med: 3.74 Max: 8.98
Current: 8.98
3.2
8.98
Quick Ratio 8.87
IRTC's Quick Ratio is ranked higher than
52% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. IRTC: 8.87 )
Ranked among companies with meaningful Quick Ratio only.
IRTC' s Quick Ratio Range Over the Past 10 Years
Min: 3.03  Med: 3.61 Max: 8.87
Current: 8.87
3.03
8.87
Days Inventory 19.80
IRTC's Days Inventory is ranked higher than
95% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.79 vs. IRTC: 19.80 )
Ranked among companies with meaningful Days Inventory only.
IRTC' s Days Inventory Range Over the Past 10 Years
Min: 19.8  Med: 24.37 Max: 28.19
Current: 19.8
19.8
28.19
Days Sales Outstanding 53.58
IRTC's Days Sales Outstanding is ranked higher than
65% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.76 vs. IRTC: 53.58 )
Ranked among companies with meaningful Days Sales Outstanding only.
IRTC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.58  Med: 56.33 Max: 98.23
Current: 53.58
53.58
98.23
Days Payable 36.76
IRTC's Days Payable is ranked lower than
71% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.53 vs. IRTC: 36.76 )
Ranked among companies with meaningful Days Payable only.
IRTC' s Days Payable Range Over the Past 10 Years
Min: 36.23  Med: 36.76 Max: 41.25
Current: 36.76
36.23
41.25

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 12.32
IRTC's Price-to-Net-Cash is ranked lower than
99.99% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.17 vs. IRTC: 12.32 )
Ranked among companies with meaningful Price-to-Net-Cash only.
IRTC' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 10.99  Med: 10.99 Max: 12.32
Current: 12.32
10.99
12.32
Price-to-Net-Current-Asset-Value 10.19
IRTC's Price-to-Net-Current-Asset-Value is ranked lower than
99.99% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.18 vs. IRTC: 10.19 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
IRTC' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 9.09  Med: 9.09 Max: 10.19
Current: 10.19
9.09
10.19
Price-to-Tangible-Book 8.12
IRTC's Price-to-Tangible-Book is ranked lower than
75% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. IRTC: 8.12 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
IRTC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 7.24  Med: 7.24 Max: 8.12
Current: 8.12
7.24
8.12
Price-to-Median-PS-Value 1.00
IRTC's Price-to-Median-PS-Value is ranked lower than
99.99% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. IRTC: 1.00 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
IRTC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.89  Med: 0.89 Max: 1
Current: 1
0.89
1
Earnings Yield (Greenblatt) % -2.33
IRTC's Earnings Yield (Greenblatt) % is ranked lower than
71% of the 267 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.18 vs. IRTC: -2.33 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
IRTC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -2.67  Med: 0 Max: 1681.04
Current: -2.33
-2.67
1681.04

More Statistics

Revenue (TTM) (Mil) $64.07
EPS (TTM) $ -2.52
Short Percentage of Float25.88%
52-Week Range $22.16 - 40.48
Shares Outstanding (Mil)22.15

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 88 117 147
EPS ($) -1.17 -0.75 0.04
EPS without NRI ($) -1.17 -0.75 0.04
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for IRTC

Headlines

Articles On GuruFocus.com
iRhythm Technologies to Report First Quarter 2017 Financial Results on May 3, 2017 Apr 19 2017 
Zio by iRhythm Gains Further Recognition as Key Diagnostic Cardiac Monitoring System by US and UK He Apr 10 2017 

More From Other Websites
iRhythm Technologies to Report First Quarter 2017 Financial Results on May 3, 2017 Apr 19 2017
iRhythm Technologies, Inc. breached its 50 day moving average in a Bearish Manner : IRTC-US : April... Apr 13 2017
Zio by iRhythm Gains Further Recognition as Key Diagnostic Cardiac Monitoring System by US and UK... Apr 10 2017
ETFs with exposure to iRhythm Technologies, Inc. : April 5, 2017 Apr 05 2017
iRhythm Technologies, Inc. :IRTC-US: Earnings Analysis: 2016 By the Numbers : April 4, 2017 Apr 04 2017
To Translate Medical Science Effectively, Researchers Must Understand Commercialization Mar 28 2017
iRhythm Technologies Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017... Feb 15 2017
iRhythm Technologies to Report Fourth Quarter and 2016 Financial Results on February 15, 2017 Feb 01 2017
A tiny patch powering big data is changing the way we monitor heartbeats Jan 30 2017
HealthEquity, Olin Break Out; iRhythm, Copart Near Buy Range Jan 10 2017
Here are the Bay Area's IPO winners and losers for 2016 Dec 28 2016
Analysts Tout Pandora Deal; Nucor, Steel Dynamics Upgraded Dec 06 2016
Look For Irhythm Technologies Inc (IRTC) To Groove Higher Nov 09 2016
Why You Should Buy iRhythm Technologies' Stock Right Now Nov 08 2016
7 IPOs on Calendar for Week of October 24 Oct 23 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)